T11426 |
Gly-β-MCA |
Gly-β-MCA, a bile acid, is a sable, intestine-selective, and oral bioactive farnesoid X receptor (FXR) inhibitor. |
T11428 |
Glyco-Obeticholic acid |
Glyco-Obeticholic acid is an active metabolite of Obeticholic acid. Obeticholic acid is an agonist of the farnesoid X receptor (FXR). |
T12583L |
(-)-PX20606 trans isomer |
(-)-PX20606 trans isomer is an agonist of FXR (EC50s: 18 and 29 nM for FXR in FRET and M1H assay, respectively). |
T13092 |
Tauro-Obeticholic acid |
Tauro-Obeticholic acid is an active Obeticholic acid metabolite. Obeticholic acid is an orally bioavailable agonist of farnesoid-X receptor (FXR). |
T13093 |
Tauro-β-muricholic acid sodium |
Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM). |
T15818 |
LY367385 |
LY367385 is a highly effective and selective mGluR1a antagonist. LY367385 has neuroprotective, anticonvulsant, and antiepileptic effects. Compared with > 100 μ...
|
T1789 |
Obeticholic Acid |
Obeticholic acid is a Farnesoid X Receptor Agonist. The mechanism of action of obeticholic acid is as a Farnesoid X Receptor Agonist. |
T2015 |
Fexaramine |
Fexaramine is a small molecule farnesoid X receptor (FXR) agonist with 100-fold increased affinity compared to natural compounds. |
T2202 |
Lithocholic acid |
Lithocholic acid is a bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubil...
|
T2233 |
GW 4064 |
GW 4064 is an effective farnesoid X receptor (FXR) agonist (EC50 =65 nM). |
T2968 |
Hyodeoxycholic acid |
Hyodeoxycholic Acid has been used in trials studying the treatment of Hypercholesterolemia. |
T4379 |
Tropifexor |
Tropifexor is a novel and highly potent agonist of FXR with an EC50 of 0.2 nM. |
T5264 |
Androsterone |
Androsterone is a metabolic product of testosterone and can activate Farnesoid X Receptor (FXR). |
T6053 |
Turofexorate Isopropyl |
Turofexorate Isopropyl (XL335) is a potent, selective, and orally bioavailable FXR agonist with EC50 of 4 nM |
T6344 |
Sevelamer HCl |
Sevelamer HCl is a phosphate binding drug used to treat hyperphosphatemia via binding to dietary phosphate and prevents its absorption. |
T6690 |
T0901317 |
T0901317 is a potent and selective agonist for both LXR and FXR, with EC50 of ~50 nM and 5 μM, respectively; it inhibits nuclear factor/κB (NF/κB). |
T7436 |
Cilofexor |
Cilofexor inhibits binding of a synthetic peptide, Cilofexor is a farnesoid X receptor (FXR) agonist. |
T7886 |
Nidufexor |
Nidufexor is an agonist for the farnesoid X receptor (FXR). |
T8471 |
Vonafexor |
Vonafexor is a farnesoid X receptor (FXR, NR1H4) agonist, with anti-HBV effects |
T8895 |
Altenusin |
Altenusin is a natural nonsteroidal fungal metabolite, as a novel selective agonist of FXR with an EC50 value of 3.2 ± 0.2 μM. |
TN4628 |
Nelumol A |
Nelumol A, and nelumal A show a potency comparable to the endogenous ligand, they may as a valuable potential novel lead compound in the search for FXR agonists...
|
TQ0252 |
BAR502 |
BAR502 is a dual GPBAR1 and FXR agonist (IC50s: 0.4 μM and 2 μM). |